Search

Search Constraints

You searched for: Author/Creator Kawaratani, Hideto

Search Results

1. A genome‐wide association study identifying SVEP1 variant as a predictor of response to tolvaptan for cirrhotic ascites. (8th August 2021)

2. Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein. (10th October 2018)

3. Angiotensin Receptor Blockers Potentiate the Protective Effect of Branched‐Chain Amino Acids on Skeletal Muscle Atrophy in Cirrhotic Rats. Issue 24 (1st November 2021)

4. Bile acid dysmetabolism in the gut‐microbiota‐liver axis under hepatitis C virus infection. (5th September 2021)

5. Blocking development of liver fibrosis augments hepatic progenitor cell‐derived liver regeneration in a mouse chronic liver injury model. Issue 9 (29th May 2019)

6. Cell‐free and concentrated ascites reinfusion therapy versus large‐volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study. Issue 3 (3rd December 2022)

7. Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase‐4 inhibitor on hepatic fibrosis. Issue 10 (15th July 2019)

8. Combined treatment with dipeptidyl peptidase‐4 inhibitor (sitagliptin) and angiotensin‐II type 1 receptor blocker (losartan) suppresses progression in a non‐diabetic rat model of steatohepatitis. Issue 12 (13th February 2017)

9. Cross talk between toll‐like receptor‐4 signaling and angiotensin‐II in liver fibrosis development in the rat model of non‐alcoholic steatohepatitis. Issue 4 (25th March 2013)

10. Diagnostic yield of liquid‐based cytology in serial pancreatic juice aspiration cytological examination. Issue 1 (25th October 2022)